Colorectal Cancer Clinical Trials in Philadelphia

Showing 181-200 of 306 trials

Safety and Efficacy Study of AMG 820 and Pembrolizumab Combination in Select Advanced Solid Tumor Cancer

NCT02713529

A multi-center Phase 1b/2 study testing the combination of AMG 820 and pembrolizumab in subjects with select advanced solid tumors.

Pancreatic CancerColorectal CancerNon-Small Cell Lung Cancer

AmMax Bio, Inc.117 participantsStarted Apr 2016

Atlanta, Georgia, United States • Boston, Massachusetts, United States • Boston, Massachusetts, United States +12 more locations

WITHDRAWNPhase 2< 1 mile

Local Consolidative Therapy in Colorectal Cancer

NCT05062720

This is a Phase II randomized multisite trial to study the effect of a combination of local consolidative therapy with systemic therapy in subjects with oligometastatic colorectal cancer who have progressed on the first line of therapy.

Colorectal Cancer Metastatic

Fox Chase Cancer CenterStarted Jul 2021

Philadelphia, Pennsylvania, United States

COMPLETEDNA< 1 mile

Life After Cancer: Behavioral Treatment Study to Improve Quality of Life

NCT00473941

The purpose of the study is to find new ways to improve the quality of life of people who have been treated for colon or rectal cancer.

Colorectal Cancer

Temple University193 participantsStarted Sep 2005

Philadelphia, Pennsylvania, United States

Safety and Efficacy Study of AMG 820 and Pembrolizumab Combination in Select Advanced Solid Tumor Cancer

Local Consolidative Therapy in Colorectal Cancer

Life After Cancer: Behavioral Treatment Study to Improve Quality of Life

Colorectal Cancer Trials in Other Cities

Circulating Tumor Material in Colorectal Cancer and Melanoma

NSABP Patient Registry and Biospecimen Profiling Repository

Study of Neratinib +Trastuzumab or Neratinib + Cetuximab in Patients With KRAS/NRAS/BRAF/PIK3CA Wild-Type Metastatic Colorectal Cancer by HER2 Status

Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers

Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy

Effect of Hemp-CBD on Patients With CIPN

5-Fluorouracil, Bevacizumab, and Radiation Followed by Modified FOLFOX6 and Bevacizumab in Stage II/III Rectal Cancer

Choice Architecture and Mailed Colorectal Cancer Screening Outreach in a Community Health Setting

A Phase 1 Study to Evaluate MEDI4736 in Combination With Tremelimumab

A Study of PDR001 in Combination With LCL161, Everolimus or Panobinostat

A Study of PDR001 in Combination With CJM112, EGF816, Ilaris® (Canakinumab) or Mekinist® (Trametinib)

Bevacizumab and Cetuximab in Combination With FOLFOX6 in Patients With Metastatic Colorectal Cancer

A Study of LY3214996 Administered Alone or in Combination With Other Agents in Participants With Advanced/Metastatic Cancer

Study of Durvalumab (MEDI4736) After Chemo-Radiation for Microsatellite Stable Stage II-IV Rectal Cancer

MGD007 Combined With MGA012 in Relapsed/Refractory Metastatic Colorectal Cancer

EL CENTRO: Engaging Latinos in the Center of Cancer Treatment Options

Phase I/Ib Study of NIS793 in Combination With PDR001 in Patients With Advanced Malignancies.

Other Conditions in Philadelphia